ADVIA Centaur EBV-VCA IgM
K-Number: K233606 · 2024-08-07
Device Summary
Frequently Asked Questions
What is the ADVIA Centaur EBV-VCA IgM?
ADVIA Centaur EBV-VCA IgM is a medical device that received FDA 510(k) clearance on 2024-08-07. The listed applicant is Biokit, S.A.. The 510(k) number is K233606.
When did ADVIA Centaur EBV-VCA IgM receive FDA 510(k) clearance?
ADVIA Centaur EBV-VCA IgM received FDA 510(k) clearance on 2024-08-07, under 510(k) number K233606.
Who is the listed applicant for ADVIA Centaur EBV-VCA IgM?
The FDA 510(k) record lists Biokit, S.A. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ADVIA Centaur EBV-VCA IgM?
The FDA product code for ADVIA Centaur EBV-VCA IgM is LSE.
Other records listing Biokit, S.A. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: LSE)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.